UB Paderborn / Katalog / Suche / in CDI

Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)

Annals of oncology, 2007-02, Vol.18 (2), p.324-330

2007

Volltextzugriff (PDF)

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients : a Southern Italy Cooperative Oncology Group phase II study

Cancer chemotherapy and pharmacology, 2005-11, Vol.56 (5), p.481-486

2005

Volltextzugriff (PDF)

Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2000-07, Vol.18 (13), p.2529-2536

2000

Volltextzugriff (PDF)

Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

Oncology, 2005-01, Vol.68 (4-6), p.438-445

2005

Volltextzugriff (PDF)

Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Annals of oncology, 2002-06, Vol.13 (6), p.866-873

2002

Volltextzugriff (PDF)

Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group

Journal of clinical oncology, 2000-04, Vol.18 (7), p.1451-1457

2000

Volltextzugriff (PDF)

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial

British journal of cancer, 1996-12, Vol.74 (11), p.1805-1811

1996

Volltextzugriff (PDF)

Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patients

European journal of cancer (1990), 1998-10, Vol.34 (11), p.1710-1714

1998

Volltextzugriff (PDF)

Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study

Lung cancer (Amsterdam, Netherlands), 2000-06, Vol.28 (3), p.237-244

2000

Volltextzugriff (PDF)

Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology Group

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1526-1534

1999

Volltextzugriff (PDF)

Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients : relationship with response to therapy and survival

Cancer Immunology, Immunotherapy, 2000-12, Vol.49 (10), p.530-536

2000

Volltextzugriff (PDF)

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano

British journal of cancer, 1996-12, Vol.74 (11), p.1805-1811

1996

Volltextzugriff (PDF)

Cisplatin, Gemcitabine, and Paclitaxel in Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: A Phase I-II Study

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2316-2325

1999

Volltextzugriff (PDF)

Duovent compared to carbuterol in the treatment of bronchospasm

Respiration, 1986, Vol.50 Suppl 2, p.177

1986

Volltextzugriff (PDF)

Cisplatin(P)-including triplets versus P-free doublets in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC): SICOG 0101 randomized trial

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7103-7103

2006

Volltextzugriff (PDF)

Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer A retrospective analysis of the Southern Italy Cooperative Oncology Group trials

Critical reviews in oncology/hematology, 2008-02, Vol.65 (2), p.164-171

2008

Volltextzugriff (PDF)

Taxol plus Gemcitabine and Vinorelbine Given Every Other Week in Advanced Chemo-Naïve Non-Small Cell Lung Cancer Patients

Oncology, 2003-01, Vol.65 (4), p.378-379

2003

Volltextzugriff (PDF)

Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: A multicenter randomized clinical trial

Cancer, 1996-07, Vol.78 (1), p.63-69

1996

Volltextzugriff (PDF)

Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Annals of oncology, 2002-06, Vol.13 (6), p.866-873

2002

Volltextzugriff (PDF)

Taxol-gemcitabine-vinorelbine (TGV) given every 2 weeks in chemo-naive advanced NSCLC. A SICOG phase I study

European journal of cancer (1990), 2001-04, Vol.37, p.S49-S49

2001

Volltextzugriff (PDF)

Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients : A phase I/II study of the Southern Italy Cooperative Oncology Group

Oncology, 2001-01, Vol.60 (2), p.127-133

2001

Volltextzugriff (PDF)

Long-term treatment with 'Duovent' in elderly patients affected by chronic obstructive lung disease

Respiration, 1986, Vol.50 Suppl 2, p.245

1986

Volltextzugriff (PDF)

Weekly cisplatin-paclitaxel-topotecan (CPT) as front-line therapy for extensive disease small cell lung cancer (ED-SCLC). A Southern Italy Cooperative Oncology Group (SICOG) phase II study

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.51-51

2000

Volltextzugriff (PDF)

Cisplatin — gemcitabine — paclitaxel (PGT) in the treatment of advanced non-small-cell lung cancer (NSCLC). A southern Italy cooperative oncology group (SICOG) phase II study

European journal of cancer (1990), 1999-09, Vol.35, p.S256-S256

1999

Volltextzugriff (PDF)

Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.79-79

2000

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients : a Southern Italy Cooperative Oncology Group phase II study

Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial

Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patients

Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study

Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology Group

Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients : relationship with response to therapy and survival

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano

Cisplatin, Gemcitabine, and Paclitaxel in Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: A Phase I-II Study

Duovent compared to carbuterol in the treatment of bronchospasm

Cisplatin(P)-including triplets versus P-free doublets in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC): SICOG 0101 randomized trial

Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer A retrospective analysis of the Southern Italy Cooperative Oncology Group trials

Taxol plus Gemcitabine and Vinorelbine Given Every Other Week in Advanced Chemo-Naïve Non-Small Cell Lung Cancer Patients

Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: A multicenter randomized clinical trial

Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Taxol-gemcitabine-vinorelbine (TGV) given every 2 weeks in chemo-naive advanced NSCLC. A SICOG phase I study

Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients : A phase I/II study of the Southern Italy Cooperative Oncology Group

Long-term treatment with 'Duovent' in elderly patients affected by chronic obstructive lung disease

Weekly cisplatin-paclitaxel-topotecan (CPT) as front-line therapy for extensive disease small cell lung cancer (ED-SCLC). A Southern Italy Cooperative Oncology Group (SICOG) phase II study

Cisplatin — gemcitabine — paclitaxel (PGT) in the treatment of advanced non-small-cell lung cancer (NSCLC). A southern Italy cooperative oncology group (SICOG) phase II study

Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

Suchergebnisse filtern